Dividends Calendar Earnings Calendar
CHRS

CHRS | Coherus Biosciences Inc

Coherus Biosciences Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Redwood City, California, United States

Trade prices

  • Volume:
  • Market Cap: 1.35B
  • Prev closed:
  • Open:
  • High:
  • Low:
  • 52 week low:
  • 52 week high:
  • Dividends:No Dividends

Next ER: November 8, 2021  After Market Closes



Top Stories (CHRS)

    Company Profile

    Coherus BioSciences, Inc. is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that may expand patient access to life-changing medicines in regulated markets worldwide. In 2018, the U.S. Food and Drug Administration approved Coherus? biosimilar UDENYCA® (pegfilgrastim-cbqv). Coherus is headquartered in the heart of California?s Silicon Valley and composed of a team of industry veterans with decades of experience pioneering biologics companies.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 3, 2022
    November 8, 2021-0.49 / -0.34682.5M / 90.69M
    August 5, 2021-0.4 / -0.2187.64M / 87.04MBeat!
    May 6, 2021-2.37 / -0.206783.03M / 96.2M
    February 24, 20210.12 / 0.2149110.42M / 114.89M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 26, 2021 18.37 18.65
    18.94
    17.91
    451.74K -2.96%
    Nov 24, 2021 18.93 18.70
    19.00
    18.51
    321.73K 0.75%
    Nov 23, 2021 18.79 18.25
    18.89
    18.09
    645.66K 2.57%
    Nov 22, 2021 18.32 18.63
    18.85
    18.10
    423.27K -1.03%
    Nov 19, 2021 18.51 18.45
    18.82
    18.12
    540.21K -0.05%
    Nov 18, 2021 18.52 18.44
    18.57
    18.03
    697.65K 0.33%
    Nov 17, 2021 18.46 18.76
    18.97
    18.28
    511.81K -2.79%
    Nov 16, 2021 18.99 18.91
    19.32
    18.62
    499.51K 0.37%
    Nov 15, 2021 18.92 18.78
    19.12
    18.53
    642.11K 1.61%
    Nov 12, 2021 18.62 18.51
    18.97
    18.40
    480.63K 0.59%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Employees:291

    News

    News for (CHRS)

    This company doesn't provide a dividend.


    Talk about Coherus Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 8, 2021 (Same day)

    znga pypl trip newr coty edit sanm mwa cara lmnd wbt jkhy 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 80
    HOLD 20
    SELL 0

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.